Skip to content

Prospective Study to Evaluate Outcomes From Transoral BOT Resection for OSAHS

Prospective Study to Evaluate Outcomes From Transoral Base of Tongue Resection for Obstructive Sleep Apnea Hypopnea Syndrome

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01107795
Enrollment
41
Registered
2010-04-21
Start date
2010-03-04
Completion date
2019-07-26
Last updated
2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS)

Brief summary

This is a prospective observational study that will collect outcome data for patients who choose to undergo transoral tongue base operations for Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS)as part of their standard of care treatment. This is a data collection study only and does not provide for evaluations or treatment of OSAHS.

Detailed description

Obstructive sleep apnea hypopnea syndrome (OSAHS) is a major public health problem, and studies suggest that the incidence of OSAHS may be even higher than estimated. Transoral base of tongue resections are commonly preformed to improve symptoms in OSAHS, but among surgeons there is not yet consensus as to the best tongue base operation. The difficulty in treating the tongue base is illustrated by the abundance of available procedures - including genioglossus advancement, hyoid advancement, tongue base suspension, radiofrequency treatment, transoral midline glossesctomy, submucosal coblation-assisted tongue base resection and recently; transoral robotic-assisted surgery (TORS) for base of tongue (BOT) resection. We will evaluate TORS BOT resection for use in OSAHS by assessing pre- and post-operative OSAHS scores and comparing them to historical data for alternative BOT operations. Though routine, BOT resection may result in significant post-operative pain leading to dysphagia. In certain patients, major complications such as aspiration pneumonia, malnutrition and dehydration can occur as a result. Thus, reducing post-operative dysphagia is critical to improving patient outcomes and limiting complication-associated hospital admissions. Several studies have addressed the management of post-operative dysphagia, but none have evaluated TORS BOT resections in OSAHS. Additionally, TORS BOT resections for malignant neoplasms have been previously shownto be safe and feasible. An outcome analysis of TORS BOT resections for OSAHS may therefore yield recommendations for reducing patient morbidity and mortality.

Interventions

Base of tongue resection with transoral robotic-assisted surgery (TORS).

Sponsors

University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Any patient with documented OSAHS who is scheduled for tongue base resection at UAB 2. Age \> 18 3. Patients must sign informed consent

Exclusion criteria

1. Psychological condition that renders the patient unable to understand the informed consent 2. Any situation or condition that will interfere with adherence to study activities

Design outcomes

Primary

MeasureTime frameDescription
Improvement in Apnea Hypopnea Index (AHI) ScoreBaseline, 3 months, 6 monthsImprovement in Apnea Hypopnea Index (AHI) score, as measured by a polysomnogram sleep study. The AHI score is the number of apnea events per hour, with a lower score indicating mild sleep apnea and a higher score indicating severe sleep apnea. An improved AHI score would be a lower score at 6 months than at 3 months and baseline.

Countries

United States

Participant flow

Participants by arm

ArmCount
Transoral BOT
Participants who received transoral base of tongue surgery as treatment for OASHS.
41
Total41

Baseline characteristics

CharacteristicTransoral BOT
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
2 Participants
Age, Categorical
Between 18 and 65 years
39 Participants
Number of Participants Stratified by Apnea Hypopnea Index (AHI) score
Mild apnea (AHI score of 0 to 14.99)
8 participants
Number of Participants Stratified by Apnea Hypopnea Index (AHI) score
Moderate apnea (AHI score of 15 to 29.99)
5 participants
Number of Participants Stratified by Apnea Hypopnea Index (AHI) score
no recorded AHI score available
11 participants
Number of Participants Stratified by Apnea Hypopnea Index (AHI) score
Severe apnea (AHI score of 30 or higher)
17 participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
10 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
31 Participants
Region of Enrollment
United States
41 participants
Sex: Female, Male
Female
8 Participants
Sex: Female, Male
Male
33 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 41
other
Total, other adverse events
4 / 41
serious
Total, serious adverse events
2 / 41

Outcome results

Primary

Improvement in Apnea Hypopnea Index (AHI) Score

Improvement in Apnea Hypopnea Index (AHI) score, as measured by a polysomnogram sleep study. The AHI score is the number of apnea events per hour, with a lower score indicating mild sleep apnea and a higher score indicating severe sleep apnea. An improved AHI score would be a lower score at 6 months than at 3 months and baseline.

Time frame: Baseline, 3 months, 6 months

Population: Participant attrition rate was very high; no data were collected.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026